Balboa Wealth Partners Harvard Bioscience Inc Transaction History
Balboa Wealth Partners
- $398 Million
- Q1 2025
A detailed history of Balboa Wealth Partners transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Balboa Wealth Partners holds 11,250 shares of HBIO stock, worth $3,937. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,250Holding current value
$3,937% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HBIO
# of Institutions
96Shares Held
26.1MCall Options Held
8.7KPut Options Held
2K-
Amh Equity LTD3.39MShares$1.19 Million3.14% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$995,2770.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.19MShares$765,6250.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.14MShares$748,5620.0% of portfolio
-
Royce & Associates LP1.78MShares$622,2620.01% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $14.6M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...